Indication: To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. For the treatment of urinary tract infections due to susceptible strains of the following organisms: Escherichia coli, Klebsiella Enterobacter Morganella morganii, Proteus mirabilis Proteus vulgaris. For the treatment of acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae Haemophilus influenzae For the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Streptococcus pneumoniae Haemophilus influenzae For the treatment of enteritis caused by susceptible strains of Shigella flexneri Shigella sonnei Pneumocystis jirovecii Pneumocystis jirovecii P. jirovecii P. jirovecii For the treatment of traveler's diarrhea due to susceptible strains of enterotoxigenic E.

Indication: To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. For the treatment of urinary tract infections due to susceptible strains of the following organisms: Escherichia coli, Klebsiella Enterobacter Morganella morganii, Proteus mirabilis Proteus vulgaris. For the treatment of acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae Haemophilus influenzae For the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Streptococcus pneumoniae Haemophilus influenzae For the treatment of enteritis caused by susceptible strains of Shigella flexneri Shigella sonnei Pneumocystis jirovecii Pneumocystis jirovecii P. jirovecii P. jirovecii For the treatment of traveler’s diarrhea due to susceptible strains of enterotoxigenic E.

Indication: Sulfamethoxazole and Trimethoprim Injection is a combination of sulfamethoxazole, a sulfonamide antimicrobial, and trimethoprim, a dihydrofolate reductase inhibitor antibacterial, indicated in adults and pediatric patients two months of age and older for treatment of infections caused by designated, susceptible bacteria. Pneumocystis jirovecii 1. 1 Shigellosis ( 1. 2 Urinary Tract Infections ( 1. 3 To reduce the development of drug-resistant bacteria and maintain the effectiveness of Sulfamethoxazole and Trimethoprim Injection and other antibacterial drugs, Sulfamethoxazole and Trimethoprim Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. 4 Sulfamethoxazole and Trimethoprim Injection is indicated in the treatment of Pneumocystis jirovecii Sulfamethoxazole and Trimethoprim Injection is indicated in the treatment of enteritis caused by susceptible strains of Shigella flexneri Shigella sonnei Sulfamethoxazole and Trimethoprim Injection is indicated in the treatment of severe or complicated urinary tract infections in adults and pediatric patients two months of age and older due to susceptible strains of Escherichia coli, Klebsiella Enterobacter Morganella morganii, Proteus mirabilis and Proteus vulgaris To reduce the development of drug-resistant bacteria and maintain the effectiveness of Sulfamethoxazole and Trimethoprim Injection and other antibacterial drugs, Sulfamethoxazole and Trimethoprim Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. Although appropriate culture and susceptibility studies should be performed, therapy may be started while awaiting the results of these studies.

Indication: To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. For the treatment of urinary tract infections due to susceptible strains of the following organisms: Escherichia coli, Klebsiella Enterobacter Morganella morganii, Proteus mirabilis Proteus vulgaris. For the treatment of acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae Haemophilus influenzae For the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Streptococcus pneumoniae Haemophilus influenzae For the treatment of enteritis caused by susceptible strains of Shigella flexneri Shigella sonnei Pneumocystis jirovecii Pneumocystis jirovecii P. jirovecii P. jirovecii For the treatment of traveler's diarrhea due to susceptible strains of enterotoxigenic E.

Indication: To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. For the treatment of urinary tract infections due to susceptible strains of the following organisms: Escherichia coli, Klebsiella Enterobacter Morganella morganii, Proteus mirabilis Proteus vulgaris. For the treatment of acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae Haemophilus influenzae For the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Streptococcus pneumoniae Haemophilus influenzae For the treatment of enteritis caused by susceptible strains of Shigella flexneri Shigella sonnei Pneumocystis jirovecii Pneumocystis jirovecii P. jirovecii P. jirovecii For the treatment of traveler’s diarrhea due to susceptible strains of enterotoxigenic E.

Indication: To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. For the treatment of urinary tract infections due to susceptible strains of the following organisms: Escherichia coli, Klebsiella Enterobacter Morganella morganii, Proteus mirabilis Proteus vulgaris. For the treatment of acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae Haemophilus influenzae For the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Streptococcus pneumoniae Haemophilus influenzae For the treatment of enteritis caused by susceptible strains of Shigella flexneri Shigella sonnei Pneumocystis jirovecii Pneumocystis jirovecii P. jirovecii P. jirovecii For the treatment of traveler’s diarrhea due to susceptible strains of enterotoxigenic E.